| Financial Year |
March 31 2023 |
| Monetary Funds |
19,269,000,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,440,000,000.00 |
| Advances to Suppliers |
757,000,000.00 |
| Other Receivables |
1,937,000,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,535,000,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
147,000,000.00 |
| Other Current Assets |
5,723,000,000.00 |
| Total Current Assets |
32,836,000,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
699,000,000.00 |
| Long-term Equity Investment |
6,290,000,000.00 |
| Investment Properties |
372,000,000.00 |
| Fixed Assetes |
90,939,000,000.00 |
| Under-construction Projects |
33,750,000,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,449,000,000.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
605,000,000.00 |
| Deferred Income Tax Assets |
12,473,000,000.00 |
| Other Non-Current Assets |
953,000,000.00 |
| Sub-Total of Non-Current Assets |
275,924,000,000.00 |
| Total Assets |
308,760,000,000.00 |
| Short-Term Loans |
57,193,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
18,031,000,000.00 |
| Accounts Received In Advance |
4,515,000,000.00 |
| Employee Compensation Payable |
3,467,000,000.00 |
| Taxes Payable |
500,000,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,531,000,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,985,000,000.00 |
| Other Current Liabilities |
11,764,000,000.00 |
| Sub-Total of Current Liabilities |
140,215,000,000.00 |
| Long-term Loans |
18,070,000,000.00 |
| Bonds Payable |
19,194,000,000.00 |
| Long-Term Accounts Payable |
255,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,000,000.00 |
| Other Non-Current Liabilities |
7,370,000,000.00 |
| Sub-Total of Non-Current Liabilities |
115,155,000,000.00 |
| Total Liabilities |
255,370,000,000.00 |
| Paid-In Capital(Or Share Stock) |
18,121,000,000.00 |
| Capital Surplus |
52,775,000,000.00 |
| Surplus Reserve |
2,579,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-34,577,000,000.00 |
| Minority Stockholder's Interest |
14,231,000,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,159,000,000.00 |
| Owner's Equity（Stockholder's Equity） |
53,390,000,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
308,760,000,000.00 |
